Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2
Carregando...
Citações na Scopus
49
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
FEDERATION AMER SOC EXP BIOL
Autores
VIVARINI, Aislan de Carvalho
PEREIRA, Renata de Meirelles Santos
TEIXEIRA, Karina Luiza Dias
CALEGARI-SILVA, Teresa Cristina
BELLIO, Maria
SOARES, Rodrigo Pedro
SILVA, Aristobolo Mendes
Citação
FASEB JOURNAL, v.25, n.12, p.4162-4173, 2011
Resumo
We investigated the type I interferon (IFN-1)/PKR axis in the outcome of the Leishmania (Leishmania) amazonensis infection, along with the underlying mechanisms that trigger and sustain this signaling pathway. Reporter assays of cell extracts from RAW-264.7 macrophages infected with L. (L.) amazonensis or HEK-293T cells cotransfected with TLR2 and PKR promoter constructions were employed. Primary macrophages of TLR2-knockout (KO) or IFNR-KO mice were infected, and the levels of PKR, IFN-1, and superoxide dismutase 1 (SOD1) transcript levels were investigated and compared. Immunohistochemical analysis of human biopsy lesions was evaluated for IFN-1 and PKR-positive cells. Leishmania infection increased the expression of PKR and IFN-beta on induction of PKR-promoter activity. The observed effects required the engagement of TLR2. TLR2-KO macrophages expressed low IFN-beta and PKR levels postinfection with a reduced parasite load. We also revealed the requirement of PKR signaling for Leishmania-induced IFN-1 expression, responsible for sustaining PKR expression and enhancing infection. Moreover, during infection, SOD1 transcripts increased and were also enhanced when IFN-1 was added to the cultures. Remarkably, SOD1 expression was abrogated in infected, dominant-negative PKR-expressing cells. Finally, lesions of patients with anergic diffuse cutaneous leishmaniasis exhibited higher levels of PKR/IFN1-expressing cells compared to those with single cutaneous leishmaniasis. In summary, we demonstrated the mechanisms and relevance of the IFN-1/PKR axis in the Leishmania infection.-De Carvalho Vivarini, A., Pereira, R. M. S., Dias Teixeira, K. L., Calegari-Silva, T. C., Bellio, M., Laurenti, M. D., Corbett, C. E. P., de Castro Gomes, C. M., Soares, R. P., Mendes Silva, A., Silveira, F. T., Lopes, U. G. Human cutaneous leish-maniasis: interferon-dependent expression of double-stranded RNA-kinase (PKR) via TLR2. FASEB J. 25, 4162-4173 (2011). www.fasebj.org
Palavras-chave
interferon-1, Toll-like receptor 2, SOD1
Referências
- Akuffo H, 1997, J INFECT DIS, V175, P737
- Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860
- Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200
- Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234
- Turetz ML, 2002, J INFECT DIS, V186, P1829, DOI 10.1086/345772
- de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128
- Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405
- Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x
- Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
- Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5
- Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309
- Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326
- Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792
- Chai Y, 2011, MOL BIOL REP, V38, P139, DOI 10.1007/s11033-010-0087-1
- Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099
- Lykens JE, 2010, J IMMUNOL, V184, P877, DOI 10.4049/jimmunol.0902346
- Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783
- Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200
- Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC
- Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4
- Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139
- Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007
- Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009
- Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127
- Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9
- Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106
- Mattner J, 2004, J IMMUNOL, V172, P7574
- Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053
- Bonfim G., 1996, EXP PARASITOL, V84, P188
- Brittingham A, 1996, PARASITOL TODAY, V12, P444, DOI 10.1016/0169-4758(96)10067-3
- Cheung BKW, 2005, J IMMUNOL, V175, P7218
- Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250
- Giorgione JR, 1996, P NATL ACAD SCI USA, V93, P11634, DOI 10.1073/pnas.93.21.11634
- Khouri R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014394
- Kuhen KL, 1999, VIROLOGY, V254, P182, DOI 10.1006/viro.1998.9536
- Mattner J, 2000, EUR J IMMUNOL, V30, P2257, DOI 10.1002/1521-4141(2000)30:8<2257::AID-IMMU2257>3.0.CO;2-U
- Schriefer A, 2008, CURR OPIN INFECT DIS, V21, P483, DOI 10.1097/QCO.0b013e32830d0ee8
- Shankar AH, 1996, EXP PARASITOL, V84, P136, DOI 10.1006/expr.1996.0099
- Silveira FT, 1998, PARASITE IMMUNOL, V20, P19, DOI 10.1046/j.1365-3024.1998.t01-1-00126.x
- Soares RPP, 2002, MOL BIOCHEM PARASIT, V121, P213, DOI 10.1016/S0166-6851(02)00033-6
- Vargas-Inchaustegui DA, 2009, INFECT IMMUN, V77, P2948, DOI 10.1128/IAI.00154-09
- Ward SV, 2002, VIROLOGY, V296, P136, DOI 10.1006/viro.2002.1356
- *WHO, 2010, LEISHM BURD DIS
- Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2
- Wilson J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000179